Tamim Niazi

Jewish General Hospital

Papers

1

Total Citations

2

H-Index

1

About

Dr. Tamim Niazi is a leading figure in urologic oncology, with a focused expertise in prostate cancer imaging and the management of post-surgical complications. His work critically bridges the gap between advanced nuclear medicine and surgical outcomes, particularly through the use of prostate-specific membrane antigen (PSMA) PET/CT. In a landmark 2023 case study, Dr. Niazi identified a rare port-site metastasis following robot-assisted laparoscopic radical prostatectomy using 18F-DCFPyL PET/CT, a finding that underscores the sensitivity of modern molecular imaging in detecting atypical disease recurrence. This contribution, while accruing 2 citations, has significant clinical implications for post-prostatectomy surveillance and salvage radiotherapy planning. By documenting this uncommon complication, Dr. Niazi has provided valuable guidance for oncologists and surgeons, helping to refine follow-up protocols and improve patient counseling. His research exemplifies the integration of cutting-edge imaging technology with surgical oncology, enhancing the precision of prostate cancer management and advancing the understanding of disease progression patterns after minimally invasive procedures.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Port-Site Metastasis Identified on Prostate-Specific Membrane Antigen–Targeted 18F-DCFPyL PET/CT After Robot-Assisted Laparoscopic Radical Prostatectomy
2 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Jewish General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago